Warning: The NCBI web site requires JavaScript to function. more...
Scanning electron microscopy of the neuropathology of murine cerebral malaria.
Lackner P, Beer R, Helbok R, Broessner G, Engelhardt K, Brenneis C, Schmutzhard E, Pfaller K.
Malar J. 2006 Nov 24;5:116.
Related citations
Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages.
Lackner P, Burger C, Pfaller K, Heussler V, Helbok R, Morandell M, Broessner G, Tannich E, Schmutzhard E, Beer R.
Neuropathol Appl Neurobiol. 2007 Oct;33(5):560-71. Epub 2007 Apr 18.
Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria.
Lackner P, Hametner C, Beer R, Burger C, Broessner G, Helbok R, Speth C, Schmutzhard E.
Malar J. 2008 Oct 10;7:207.
Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes.
Carvalho LJ, Lenzi HL, Pelajo-Machado M, Oliveira DN, Daniel-Ribeiro CT, Ferreira-da-Cruz MF.
Exp Parasitol. 2000 May;95(1):1-7.
Behavioural and histopathological alterations in mice with cerebral malaria.
Lackner P, Beer R, Heussler V, Goebel G, Rudzki D, Helbok R, Tannich E, Schmutzhard E.
Neuropathol Appl Neurobiol. 2006 Apr;32(2):177-88.
Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation.
Pais TF, Chatterjee S.
J Neuroimmunol. 2005 Jun;163(1-2):73-83. Epub 2005 Apr 12.
Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature.
Hearn J, Rayment N, Landon DN, Katz DR, de Souza JB.
Infect Immun. 2000 Sep;68(9):5364-76.
Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei.
Polder TW, Eling WM, Curfs JH, Jerusalem CR, Wijers-Rouw M.
Acta Leiden. 1992;60(2):31-46.
Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria.
Potter S, Chan-Ling T, Ball HJ, Mansour H, Mitchell A, Maluish L, Hunt NH.
Int J Parasitol. 2006 Apr;36(4):485-96. Epub 2006 Jan 19.
Nogo-A expression in the brain of mice with cerebral malaria.
Lackner P, Beer R, Broessner G, Helbok R, Dallago K, Hess MW, Pfaller K, Bandtlow C, Schmutzhard E.
PLoS One. 2011;6(9):e25728. Epub 2011 Sep 29.
Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice.
Delahaye NF, Coltel N, Puthier D, Barbier M, Benech P, Joly F, Iraqi FA, Grau GE, Nguyen C, Rihet P.
BMC Genomics. 2007 Dec 6;8:452.
Neuropathological studies on Plasmodium yoelii nigeriensis-induced malaria in mice.
Sharma MR, Sharma MC, Tripathi LM, Pandey VC, Maitra SC.
J Comp Pathol. 1994 Apr;110(3):313-7.
Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol.
Martins YC, Werneck GL, Carvalho LJ, Silva BP, Andrade BG, Souza TM, Souza DO, Daniel-Ribeiro CT.
Malar J. 2010 Mar 24;9:85.
Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice.
Wiese L, Kurtzhals JA, Penkowa M.
Exp Neurol. 2006 Jul;200(1):216-26. Epub 2006 Apr 19.
CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines.
Van den Steen PE, Deroost K, Van Aelst I, Geurts N, Martens E, Struyf S, Nie CQ, Hansen DS, Matthys P, Van Damme J, Opdenakker G.
Eur J Immunol. 2008 Apr;38(4):1082-95.
Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.
Jennings VM, Lal AA, Hunter RL.
Infect Immun. 1998 Dec;66(12):5972-9.
Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, Luster AD.
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4814-9. Epub 2008 Mar 17.
Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model.
Lovegrove FE, Gharib SA, Peña-Castillo L, Patel SN, Ruzinski JT, Hughes TR, Liles WC, Kain KC.
PLoS Pathog. 2008 May 16;4(5):e1000068.
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
Lackner P, Part A, Burger C, Dietmann A, Broessner G, Helbok R, Reindl M, Schmutzhard E, Beer R.
Malar J. 2009 Feb 27;8:36.
Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier.
Combes V, Coltel N, Faille D, Wassmer SC, Grau GE.
Int J Parasitol. 2006 May 1;36(5):541-6. Epub 2006 Mar 10. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on